(The Center Square) – Patients' rights groups are praising President Donald Trump’s announcement of drug price transparency expansion as the first step toward price transparency in healthcare, stating that taxpayers deserve to know where their money is going.

Founder and chairman of PatientsRightsAdvocate.org (PRA) Cynthia Fisher told The Center Square: “We applaud President Trump, Secretaries Kennedy and Oz, Mark Cuban, and all those involved for expanding consumer choice in prescription drug pricing, which is a critical first step toward true price transparency in healthcare.”

Originally published on thecentersquare.com, part of the BLOX Digital Content Exchange.

Locations

Recommended for you